Atracef T 250mg/31.25mg Injection
By Atracef T
Rx
1 Injection in a Vial

Composition
Cefepime(250mg) + Tazobactum(31.25mg)

Manufacturer - Ashlife Healthcare
A-52,Old No-14-C,Khasra No 143,Near Bharat Petrol Pump,Ghazipur, Delhi, 110096, ,

Expires on or after
August, 2025

liver
When it comes to the safety of using Atracef T 250mg/31.25mg Injection for individuals with liver disease, it appears to be generally safe based on the limited information. There is no clear indication that adjusting the dose of Atracef T 250mg/31.25mg Injection is necessary for patients with liver issues. However, it is always recommended to consult with your doctor before using this medication to ensure it is suitable for your specific situation.

kidney
"Caution should be taken in patients with kidney disease when using Atracef T 250mg/31.25mg Injection. Dosage adjustment may be necessary. Consult your doctor."

alcohol
Caution is advised when consuming alcohol with Atracef T 250mg/31.25mg Injection. Consult your doctor.

driving
After using Atracef T 250mg/31.25mg Injection, your vision may be blurred briefly. Avoid driving until your vision returns to normal.

pregnancy
Atracef T 250mg/31.25mg Injection is considered safe during pregnancy based on animal studies with low risk to the baby, but limited human studies exist.

breastfeeding
Atracef T 250mg/31.25mg Injection is considered safe for use during breastfeeding. Research indicates that the medication does not pass into breastmilk in substantial quantities and poses no harm to the baby.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | ANTI INFECTIVES |
Action Class | - |
₹80
Inclusive of all taxes
Content verified by

Dr. Abdullah Khan
MBBS - General Medicine
Last update on 01-Oct-2024